REFERENCES

a. Patients can have other pathologies that could result in mixed or sometimes pure obstructive patterns.

  1. Raghu G, Brown KK. Interstitial lung disease: clinical evaluation and keys to an accurate diagnosis. Clin Chest Med. 2004;25(3);409-419, v. doi: 10.1016/j.ccm.2004.05.007.
  2. Meyer KC. Diagnosis and management of interstitial lung disease. Trans Respir Med. 2014:2:4. doi: 10.1186/2213-0802-2-4.
  3. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
  4. Van Manen MJG, Birring SS, Vancheri C, et al. Cough in idiopathic pulmonary fibrosis.
    Eur Respir Rev. 2016;25:278-286. doi: 10.1183/16000617.0090-2015.
  5. Gibson GJ, Loddenkemper R, Lundbäck B, Sibille Y. Respiratory health and disease in Europe: the new European Lung White Book. Eur Respir J. 2013;42(3):559-563. doi:10.1183/09031936.00105513.
  6. Cosgrove G, Bianchi P, Danese Sherry, et al. Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey. BMC Pulm Med. 2018;18(9):1-9.
    doi: 10.1186/s12890-017-0560-x.
  7. Nathan N, Corvol H, Amselem S, et al. Biomarkers in Interstitial lung diseases. Paed Respir Rev. 2015;16(4):219-224. doi: 10.1016/j.prrv.2015.05.002.
  8. Karnani NG, Reisfield GM, Wilson GR. Evaluation of chronic dyspnea. Am Fam Physician. 2005;71(8):1529-1537.
  9. Ryerson CJ, Collard HR. Update on the diagnosis and classification of ILD. Curr Opin Pulm Med. 2013;19(5):453-459. doi: 10.1097/MCP.0b013e328363f48d.
  10. Garcia CK, Talbert JL. Pulmonary Fibrosis Predisposition Overview. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; January 21, 2005.
  11. Schwaiblmair M, Behr W, Haeckel T, et al. Drug induced interstitial lung disease.
    Open Respir Med J. 2012;6:63-74. doi: 10.2174/1874306401206010063.
  12. Camus P. The drug- induced respiratory disease website. 2012. Pneumotox website. www.pneumotox.com. Accessed September 9, 2018.
  13. Sarkar M, Madabhavi I, Niranjan N, et al. Auscultation of the respiratory system. Ann Thorac Med. 2015;10(3):158-168. doi: 10.4103/1817-1737.160831.
  14. Cottin V, Cordier J-F. Velcro crackles: the key for early diagnosis of idiopathic pulmonary fibrosis? Eur Respir J. 2012;40(3):519-521. doi: 10.1183/09031936.00001612.
  15. Cottin V, Nunes H, Brillet P-Y, et al. Combined pulmonary fibrosis and emphysema:
    a distinct underrecognised entity. Eur Respir J. 2005;26(4):586-593.
    doi: 10.1183/09031936.05.00021005.
  16. Castelino FV, Varga J. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthr Res Ther. 2010;12(4):213.
    doi: 10.1186/ar3097.
  17. Kritek P, Choi MK. In: Longo DL, Fauco AS, Kasper DL et al., eds. Harrison’s Principles of Internal Medicine. 18th ed. New York, NY: McGraw-Hill.
  18. Ranu H, Wilde M, Madden B. Pulmonary function tests. Ulster Med J. 2011;80(2):84-90.
  19. Ley B, Collard HR, King TE. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183(4):431-440.
    doi: 10.1164/rccm.201006-0894CI.
  20. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests.
    Eur Respir J. 2005;26(5):948-968. doi: 10.1183/09031936.05.00035205.
  21. O'Brien JM. Tests of pulmonary function. In: The Merck Manual. Whitehouse Station,
    NJ: Merck Sharp & Dohme Corp. 2009-2015.
  22. Jo HE, Glaspole IN, Levin KC, et al. Clinical impact of the interstitial lung disease multidisciplinary service. Respirology. 2016;21(8):1438-1444. doi: 10.1111/resp.12850.
  23. Vij R, Strek M. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest. 2013;143(3):814-824. doi: 10.1378/chest.12-0741.
  24. Meyer KC, Raghu G. Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Eur Respir J. 2011;38(4):761-769. doi: 10.1183/09031936.00069509.
  25. Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63 Suppl 5:v1-58. doi: 10.1136/thx.2008.101691.
  26. National Heart, Lung, and Blood Institute. Chest X Ray. http://www.nhlbi.nih.gov/health/health-topics/topics/cxray/whoneeds. Accessed September 9, 2018.
  27. FDA Medical X ray Imaging. http://www.fda.gov/RadiationEmittingProducts/RadiationEmittingProductsandProcedures/Medicallmaging/MedicalX-rays/ucm115318.htm. Accessed September 9, 2018.
  28. Verschakelen JA. The role of high-resolution computed tomography in the work-up of interstitial lung disease. Curr Opin Pulm Med. 2010;16(5):503-510.
    doi: 10.1097/MCP.0b013e32833cc997.
  29. Suh RD, Goldin JG. High-resolution computed tomography of interstitial pulmonary fibrosis. Semin Respir Crit Care Med. 2006;27(6):623-633. doi: 10.1055/s-2006-957334.
  30. Walsh SLR, Hansell DM. High-resolution CT of interstitial lung disease: a continuous evolution. Semin Respir Crit Care Med. 2014;35(1):129-144. doi: 10.1055/s-0033-1363458.
  31. Cottin V. Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty. Eur Respir J. 2016;48(5):1274-1277. doi: 10.1183/13993003.01633-2016.
  32. Lynch DA, Sverzellati N, Travis WD, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med. 2018;6(2):138-153.
    doi: 10.1016/S2213-2600(17)30433-2.
  33. Tomassetti S, Wells AU, Costabel U, et al. Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2016;193(7):745-752. doi: 10.1164/rccm.201504-0711OC.
  34. Colby TV, Tomassetti S, Cavazza A, et al. Transbronchial Cryobiopsy in Diffuse Lung Disease: Update for the Pathologist. Arch Pathol Lab Med. 2016;141(7):891-900.
    doi: 10.5858/arpa.2016-0233-RA.
  35. Hutchinson JP, Fogarty AW, McKeever TM, et al. In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011. Am J Respir Crit Care Med. 2016;193(10):1161-1167. doi: 10.1164/rccm.201508-1632OC.
  36. Karimi R, Tornling G, Grunewald J, et al. Cell recovery in bronchoalveolar lavage fluid in smokers is dependent on cumulative smoking history. PLoS One. 2012;7(3):e34232.
    doi: 10.1371/journal.pone.0034232.
  37. BAL Cooperative Group Steering Committee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis. 1990;141(5 Pt 2):S169-202. doi: 10.1164/ajrccm/141.5_Pt_2.S169.
  38. Flaherty K, Andrei A-C, King TE, et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med. 2007;175(10):1054-1060. doi: 10.1164/rccm.200606-833OC.

See also

Test your Knowledge
Test your knowledge

Take the test

Lung X-Ray Example
Rad Rounds Mobile App

Download the app

Interstitial lung disease in systemic sclerosis with a focus on chest CT

Media Library

See Media